NCT07468799

Brief Summary

Neuropathic pain is a chronic condition that significantly affects quality of life and often responds poorly to conventional pharmacological treatments. Repetitive transcranial magnetic stimulation (rTMS) has emerged as a non-invasive neuromodulation technique with potential analgesic effects. This study aimed to evaluate the effectiveness of rTMS in reducing neuropathic pain intensity among patients with confirmed neuropathic pain. A clinical study was conducted involving adult patients who met diagnostic criteria for neuropathic pain. Participants received rTMS sessions targeting the motor cortex over a defined treatment period. Pain intensity was assessed using standardized pain scales before and after treatment. The study examined changes in pain scores following rTMS therapy and evaluated its potential as an adjunctive treatment for neuropathic pain. The findings of this study may contribute to understanding the therapeutic role of rTMS in the management of neuropathic pain and support its use as a non-invasive treatment option.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 13, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

March 9, 2026

Last Update Submit

March 9, 2026

Conditions

Keywords

Repetitive Transcranial Magnetic StimulationrTMSNeuromodulationChronic PainMotor Cortex Stimulation

Outcome Measures

Primary Outcomes (1)

  • Pain intensity score

    Change in neuropathic pain intensity measured using the Visual Analog Scale (VAS). Pain scores are assessed before the rTMS intervention and after completion of the treatment sessions.

    Baseline and immediately after completion of the rTMS treatment sessions

Study Arms (1)

rTMS Treatment

EXPERIMENTAL

Participants receive repetitive transcranial magnetic stimulation (rTMS) applied over the primary motor cortex as a therapeutic intervention for neuropathic pain. Clinical outcomes including pain severity and inflammatory biomarkers are assessed before and after the intervention.

Device: Repetitive Transcranial Magnetic Stimulation

Interventions

Repetitive transcranial magnetic stimulation (rTMS) delivered over the primary motor cortex using a magnetic coil to generate repeated magnetic pulses. The stimulation sessions are administered to modulate cortical excitability and reduce neuropathic pain symptoms. Participants receive multiple treatment sessions according to the study protocol, and clinical outcomes are evaluated before and after the intervention.

Also known as: rTMS
rTMS Treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults aged 18-65 years
  • Diagnosed with schizophrenia according to DSM-5 criteria
  • Experiencing neuropathic pain or chronic pain symptoms
  • Stable psychiatric medication for at least 4 weeks prior to enrollment
  • Able to provide written informed consent

You may not qualify if:

  • History of epilepsy or seizure disorders
  • Presence of metallic implants in the head
  • Severe neurological disorders
  • Substance abuse within the past 6 months
  • Pregnancy or breastfeeding
  • Contraindications to rTMS therapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasanuddin University

Makassar, South Sulawesi, 90245, Indonesia

Location

MeSH Terms

Conditions

NeuralgiaChronic Pain

Interventions

Transcranial Magnetic Stimulation

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Magnetic Field TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single-arm interventional study evaluating the effect of repetitive transcranial magnetic stimulation (rTMS) on neuropathic pain. Participants receive rTMS sessions targeting the primary motor cortex, and clinical outcomes including pain severity and inflammatory biomarkers are assessed before and after the intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Neurologist

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 13, 2026

Study Start

January 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

March 13, 2026

Record last verified: 2026-03

Locations